Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Hansa Biopharma
  4. Hansa Biopharma — Maj 2023

Hansa Biopharma — Maj 2023

Planlagt Fastgjort Låst Flyttet Hansa Biopharma
69 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    B.Andersen
    wrote on sidst redigeret af
    #49

    According to Fierce Biotech, expectations in DMD are high with SRP-9001 potentially be one of the biggest biotech product launches in 2023 with annual sales of more than USD 2 billion in less than five years". https://proinvestor.com/boards/112647/

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #50

      "Hansa Biopharma will be eligible to receive up to USD 400 million in milestones from Sarepta Therapeutics plus up to midteens in royalty payments and sales of imlifidase"

      Mandag d. 29 maj - kun lidt over en uge tilbage 🙂

      1 Reply Last reply
      0
      • M Offline
        M Offline
        MBCruise
        wrote on sidst redigeret af
        #51

        2 år gammel artikel, men meget interessant omkring Gene Therapy udbredelse og udfordringerhttps://static1.squarespace.com/static/5b5f666c9772ae3d286108fa/t/60bfd0b60c9d4d5d831e0298/1623183547382/BBLSA_WhitePaper-GeneTherapy-6-8-21.pdf

        1 Reply Last reply
        0
        • L Offline
          L Offline
          LP90
          wrote on sidst redigeret af
          #52

          Godmorgen 🙂

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #53

            @LP90 - godt du stadig holder ved 🙂

            1 Reply Last reply
            0
            • L Offline
              L Offline
              LP90
              wrote on sidst redigeret af
              #54

              Godmorgen 🙂

              1 Reply Last reply
              0
              • L Offline
                L Offline
                LP90
                wrote on sidst redigeret af
                #55

                Exitnu jeps holder stadig og køber på dip (har ret mange efterhånden både i fri og pension 🙂

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #56

                  @LP90 - Okay!

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    LP90
                    wrote on sidst redigeret af
                    #57

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #58

                      Sarepta Therapeutics Announces Update on Regulatory Review of SRP-9001

                      https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-update-regulatory-review-srp-9001?_ga=2.101235842.2073829004.1684944923-1758491174.1683956918

                      (05/24/23 8:00 AM EDT)

                      New regulatory action date is June 22, 2023 ...

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #59

                        .... CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 24, 2023-- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, today provided the following update on the Biologics License Application (BLA) for SRP-9001 (delandistrogene moxeparvovec), which is currently under review for the treatment of ambulant individuals with Duchenne muscular dystrophy (DMD) who have a confirmed mutation of the DMD gene.

                        1 Reply Last reply
                        0
                        • exitnuE Offline
                          exitnuE Offline
                          exitnu
                          wrote on sidst redigeret af
                          #60

                          .... Sarepta will remain in a quiet period for the duration of the BLA review.

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            Pensionisten
                            wrote on sidst redigeret af
                            #61

                            Så må vi jo væbne os med lidt yderligere tålmodighed. Men det går vel nok endda. 😉

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #62

                              Godmorgen 🙂 ja tålmodigheden bliver tit sat på prøve i denne her case det har været længe undervejs efterhånden en lang lang rejse men vi holder ved 🙂

                              1 Reply Last reply
                              0
                              • L Offline
                                L Offline
                                LP90
                                wrote on sidst redigeret af
                                #63

                                Godmorgen 🙂

                                1 Reply Last reply
                                0
                                • exitnuE Offline
                                  exitnuE Offline
                                  exitnu
                                  wrote on sidst redigeret af
                                  #64

                                  UPDATE: FDA needs more time for Sarepta's DMD gene therapy—spurring a deja vu of Exondys 51 (May 24, 2023 08:39am)

                                  Just a moment...

                                  favicon

                                  (www.fiercebiotech.com)

                                  "The FDA needs a wee bit more time to consider the approval of Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy (DMD), however, the agency has indicated an accelerated approval is likely in a restricted age group."

                                  1 Reply Last reply
                                  0
                                  • exitnuE Offline
                                    exitnuE Offline
                                    exitnu
                                    wrote on sidst redigeret af
                                    #65

                                    EMBARK toplinje-resultater forventes i fjerde kvartal.

                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #66

                                      RBC Capital Markets har sat et nyt Sarepta Therapeutics kursmål på USD 218 med anbefalingen Outperform ... RBC ser en smule negativt på meldingen fra FDA men anbefaler dog at købe på et tilbagefald.

                                      https://pbs.twimg.com/media/FxA6F9NWIAI6SCZ?format=png&name=900x900

                                      1 Reply Last reply
                                      0
                                      • L Offline
                                        L Offline
                                        LP90
                                        wrote on sidst redigeret af
                                        #67

                                        Godmorgen 🙂 ja så er kursen igen presset tilbage et langt sejt træk med denne her

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #68

                                          Hansa announces first patient dosed with imlifidase in a global pivotal phase 3 trial in anti-glomerular basement membrane (anti-GBM) disease

                                          Link Preview Image
                                          Hansa announces first patient dosed with imlifidase in a global pivotal phase 3 trial in anti-glomerular basement membrane (anti-GBM) disease | Hansa Biopharma

                                          favicon

                                          (www.hansabiopharma.com)

                                          (30 May 2023, 08:00)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper